Ajinomoto Bio-Pharma Services, a global provider of bio-pharmaceutical contract development and manufacturing, is expanding its capabilities and capacities. The company has several capital projects currently underway in both the U.S. and Belgium, investing more than $100 million to further expand its offerings and capabilities. In addition to the previously announced highly potent product conjugation and fully isolated fill line, which has recently began operations in its new facility in San Die...